SCHEMBL4742145

SCHEMBL4742145

O=C(CC(NC(=O)c1cnc2cc(C(F)(F)F)ccc2c1N1CCSCC1)C(=O)CF)OC(=O)C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.43
DPP4 P27487 1/20 0.34
CCRL2 O00421 1/20 0.33
MMP1 P03956 3/20 0.32
MMP9 P14780 3/20 0.32
MMP13 P45452 3/20 0.32
SCN10A Q9Y5Y9 1/20 0.32
PDGFRB P09619 1/20 0.32
CYP8B1 Q9UNU6 3/20 0.31
ADAM17 P78536 2/20 0.31
SCN9A Q15858 1/20 0.31
ADRB2 P07550 1/20 0.31
NCF1 P14598 1/20 0.31
CYP3A4 P08684 1/20 0.31
UGCG Q16739 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4739980 0.92 THRB (0.44) THRBMMP1MMP9MMP13SCN10A
SCHEMBL4785503 0.91 THRB (0.45) THRB
SCHEMBL4742120 0.91 THRB (0.43) THRBMMP1MMP9MMP13PDGFRB
SCHEMBL4785468 0.89 THRB (0.45) THRBDPP4MMP1MMP9MMP13
Trifluoroacetic Acid SCHEMBL4742140 0.88 THRB (0.43) THRBDPP4CCRL2MMP1MMP9
SCHEMBL4739340 0.85 THRB (0.40) THRBADRB2NCF1
SCHEMBL4741630 0.81 THRB (0.46) THRBMMP1MMP9MMP13CYP8B1
SCHEMBL4742118 0.80 MET (0.38) THRBCYP3A4
SCHEMBL4743062 0.80 THRB (0.47) THRB
Trifluoroacetic Acid SCHEMBL4785493 0.79 THRB (0.45) THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008093940-A1 QUINOLINE DERIVATIVES AS CASPASE-3 INHIBITOR, PREPARATION PROCESS FOR THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME YUNGJIN PHARMACEUTICAL CO., LTD. (KR) 2008-08-07 WO claimed
WO-2008093940-A1 QUINOLINE DERIVATIVES AS CASPASE-3 INHIBITOR, PREPARATION PROCESS FOR THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME YUNGJIN PHARMACEUTICAL CO., LTD. (KR) 2008-08-07 WO disclosed